# Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

> **NCT01717170** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Nebraska** · enrollment: 36 (estimated)

## Conditions studied

- Intermediate Uveitis
- Posterior Uveitis
- Pan-uveitis

## Interventions

- **DRUG:** Tocilizumab

## Key facts

- **NCT ID:** NCT01717170
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2017-06
- **Final completion:** 2017-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01717170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01717170, "Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01717170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*